查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1869713

移植诊断市场规模、份额和趋势分析报告：按检测、产品、应用、移植部位、最终用途、地区和细分市场预测（2025-2033 年）

Transplant Diagnostics Market Size, Share & Trends Analysis Report By Test, By Product, By Application, By Transplant Area, By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

移植诊断市场摘要

2024年全球移植诊断市场规模估计为63.9亿美元，预计2033年将达到121.5亿美元。

预计从 2025 年到 2033 年，该市场将以 7.45% 的复合年增长率成长。遗传疾病的日益普遍、基因检测技术的进步以及人们对个人化医疗日益增长的认识和需求正在推动市场成长。

例如，2025年10月，UBC酶技术公司启动了首个通用供体器官移植人体试验。该公司研发了一种酶，可以将肾臟转化为通用O型血，用于器官移植，这标誌着在更快、更匹配的器官捐赠方面迈出了重要一步。此外，肾臟在两天内功能正常，没有超急性排斥反应的征兆。超急性排斥反应是一种快速免疫反应，可在数分钟内破坏不匹配的器官。到第三天，一些血型标记重新出现，引发了轻微的反应。然而，这种损伤远小于典型的不匹配情况，研究征兆，人体开始对该器官产生耐受性。

此外，人口老化、慢性病流行以及移植技术的进步正在推动市场成长。例如，世界卫生组织（世卫组织）于2025年10月宣布，至2020年，60岁以上人口数将超过5岁以下儿童数。预计到2050年，全球60岁及以上人口的比例将从2015年的12%几乎翻一番，达到22%。此外，预计到2050年，80%的老年人居住在中低收入国家。与过去相比，人口老化的速度正在显着加快。随着心臟衰竭、肾臟病和肝病等慢性病的持续增加，对器官移植这种救命疗法的需求也不断增长。移植手术数量的增加凸显了精准先进的诊断工具的重要性，以确保捐赠者与受体的匹配，降低器官排斥的风险，并提高移植成功率。

目录

第一章 移植诊断市场：调查方法与范围

2. 移植诊断市场：执行摘要

  • 市场概述
  • 检查
  • 产品概览
  • 使用情况简介
  • 移植部位简介
  • 最终用途简介
  • 竞争格局概览

3. 移植诊断市场变数、趋势与范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
  • 市场驱动因素分析
    • 遗传性疾病盛行率不断上升
    • 基因检测技术的进步
    • 人们对个人化医疗的认识和需求日​​益增长
  • 市场限制因素分析
    • 有限的公共卫生检测
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第四章 移植诊断市场：检测需求估算与趋势分析

  • 移植诊断市场：检测差异分析
  • 分子检测
    • 基于PCR的分子检测
    • 即时PCR
    • 基于序列的引子PCR
    • 序列特异性寡核苷酸PCR
    • 其他基于PCR的分子检测方法
  • 基于定序的分子检测
    • 桑格定序
    • 次世代定序
    • 其他基于定序的分子检测方法
  • 非分子检测
    • 血清学检测
    • 混合淋巴球培养试验

第五章 移植诊断市场：产品估算与趋势分析

  • 移植诊断市场：产品差异分析
  • 试剂和耗材
  • 装置
  • 软体和服务

第六章 移植诊断市场：应用预测与趋势分析

  • 移植诊断市场：应用差异分析
  • 诊断用途
    • 传染病检查
    • 组织配对
    • 血液分析
  • 研究用途

第七章 移植诊断市场：移植部位估算与趋势分析

  • 移植诊断市场：移植部位变异分析
  • 固态区域移植
    • 肾臟移植
    • 肝臟移植
    • 心臟移植
    • 肺移植
    • 胰臟移植
    • 其他器官移植
  • 干细胞移植
    • 软组织移植
    • 骨髓移植

第八章 移植诊断市场：终端使用者估算与趋势分析

  • 移植诊断市场：最终用途差异分析
  • 医院及移植中心
  • 研究和学术机构
  • 独立参考实验室

9. 移植诊断市场：区域业务分析

  • 区域市场概况
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第十章 竞争格局

  • 公司分类
  • 策略规划
    • 新产品上市
    • 伙伴关係
    • 获得
    • 合作
    • 资金筹措
  • 主要企业市占率分析，2024 年
  • 公司热力图分析
  • 公司简介
    • Thermo Fisher Scientific, Inc.
    • Illumina, Inc.
    • F. Hoffmann La-Roche Ltd
    • Abbott
    • QIAGEN
    • Bruker
    • BD（Becton, Dickinson and Company）
    • Werfen（Immucor, Inc.）
    • Bio-Rad Laboratories, Inc.
    • Omixon Inc.
Product Code: 978-1-68038-970-8

Transplant Diagnostics Market Summary

The global transplant diagnostics market size was estimated at USD 6.39 billion in 2024 and is expected to reach USD 12.15 billion in 2033, growing at a CAGR of 7.45% from 2025 to 2033. The rising prevalence of genetic disorders, technological advancements in genetic testing, and growing awareness and demand for personalized medicine are boosting the market growth.

For instance, in October 2025, UBC enzyme technology introduced the first human test toward universal donor organs for transplantation. It has developed enzymes that successfully convert a kidney to universal type O for transplant, marking a significant step toward faster, more compatible organ donations. Further, the results show that the kidney functioned normally for two days without evidence of hyperacute rejection. This quick immune reaction can destroy an incompatible organ in minutes. By the third day, some blood-type markers resurfaced, causing a moderate response. Still, the damage was significantly less severe than in a usual mismatch, and researchers noticed signals that the body was starting to tolerate the organ.

Furthermore, the aging population, the prevalence of chronic disease, and advances in transplantation techniques are all driving market growth. For example, in October 2025, the World Health Organization claimed that in 2020, individuals aged 60 and older outnumbered children under five. Between 2015 and 2050, the worldwide population over 60 will almost double, from 12% to 22%. Furthermore, by 2050, 80% of older people will reside in low- and middle-income countries. The pace of population ageing is much faster than in the past. As chronic diseases such as heart failure, kidney disease, and liver disorders continue to rise, the need for organ transplantation as a life-saving treatment is also increasing. This rise in transplant procedures highlights the importance of accurate and advanced diagnostic tools to ensure donor-recipient compatibility, reduce the risk of organ rejection, and improve transplantation success rates.

Global Transplant Diagnostics Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global transplant diagnostics market report based on test, product, application, transplant area, end-use, and region:

  • Test Outlook (Revenue, USD Million, 2021 - 2033)
    • Molecular Assays
  • PCR-based Molecular Assays
  • Real-time PCR
  • Sequence-based Primer-PCR
  • Sequence-specific Oligonucleotide-PCR
  • Other PCR-based Molecular Assays
    • Sequencing-based Molecular Assays
  • Sanger Sequencing
  • Next Generation Sequencing
  • Other Sequencing-based Molecular Assays
    • Non-molecular Assays
  • Serological Assays
  • Mixed Lymphocyte Culture Assays
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
    • Reagents & Consumables
    • Instruments
    • Software and Services
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
    • Diagnostic Application
  • Infectious Disease Testing
  • Histocompatibility Testing
  • Blood Profiling
    • Research Application
  • Transplant Area Outlook (Revenue, USD Million, 2021 - 2033)
    • Solid Area Transplantation
  • Kidney Transplantation
  • Liver Transplantation
  • Heart Transplantation
  • Lung Transplantation
  • Pancreas Transplantation
  • Other Organs Transplantation
    • Stem Cell Transplantation
    • Soft Tissue Transplantation
    • Bone Marrow Transplantation
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
    • Hospitals and Transplant Centers
    • Research and Academic Institutes
    • Independent Reference Laboratories
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
    • North America
  • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Transplant Diagnostics Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Test
      • 1.1.1.2. Product Segment
      • 1.1.1.3. Application Segment
      • 1.1.1.4. Transplant Area Segment
      • 1.1.1.5. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Transplant Diagnostics Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Test
  • 2.3. Product Snapshot
  • 2.4. Application Snapshot
  • 2.5. Transplant Area Snapshot
  • 2.6. End Use Snapshot
  • 2.7. Competitive Landscape Snapshot

Chapter 3. Transplant Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Rising prevalence of genetic disorders
    • 3.4.2. Technological advancements in genetic testing
    • 3.4.3. Growing awareness and demand for personalized medicine
  • 3.5. Market Restraint Analysis
    • 3.5.1. Limited implementation of public health screening
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Transplant Diagnostics Market: Test Estimates & Trend Analysis

  • 4.1. Transplant Diagnostics Market: Test Movement Analysis
  • 4.2. Molecular Assays
    • 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.2. PCR-based Molecular Assays
      • 4.2.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.3. Real-time PCR
      • 4.2.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.4. Sequence-based Primer-PCR
      • 4.2.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.5. Sequence-specific Oligonucleotide-PCR
    • 4.2.6. Other PCR-based Molecular Assays
      • 4.2.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3. Sequencing-based Molecular Assays
    • 4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Sanger Sequencing
      • 4.3.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. Next Generation Sequencing
      • 4.3.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.4. Other Sequencing-based Molecular Assays
      • 4.3.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Non-molecular Assays
    • 4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Serological Assays
      • 4.4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Mixed Lymphocyte Culture Assays
      • 4.4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Transplant Diagnostics Market: Product Estimates & Trend Analysis

  • 5.1. Transplant Diagnostics Market: Product Movement Analysis
  • 5.2. Reagents & Consumables
    • 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3. Instruments
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Software and Services
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Transplant Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. Transplant Diagnostics Market: Application Movement Analysis
  • 6.2. Diagnostic Application
    • 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.2. Infectious Disease Testing
      • 6.2.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.3. Histocompatibility Testing
      • 6.2.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.4. Blood Profiling
  • 6.3. Research Application
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Transplant Diagnostics Market: Transplant Area Estimates & Trend Analysis

  • 7.1. Transplant Diagnostics Market: Transplant Area Movement Analysis
  • 7.2. Solid Area Transplantation
    • 7.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.2. Kidney Transplantation
      • 7.2.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.3. Liver Transplantation
      • 7.2.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.4. Heart Transplantation
      • 7.2.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.5. Lung Transplantation
      • 7.2.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.6. Pancreas Transplantation
      • 7.2.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.7. Other Organs Transplantation
      • 7.2.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3. Stem Cell Transplantation
    • 7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Soft Tissue Transplantation
      • 7.3.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Bone Marrow Transplantation
      • 7.3.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Transplant Diagnostics Market: End Use Estimates & Trend Analysis

  • 8.1. Transplant Diagnostics Market: End Use Movement Analysis
  • 8.2. Hospitals and Transplant Centers
    • 8.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3. Research and Academic Institutes
    • 8.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Independent Reference Laboratories
    • 8.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Transplant Diagnostics Market: Regional Business Analysis

  • 9.1. Regional Market Snapshot
  • 9.2. North America
    • 9.2.1. North America Transplant Diagnostics Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. U.S. Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.2.2.2. Key Country Dynamics
      • 9.2.2.3. Regulatory Framework
      • 9.2.2.4. Reimbursement Scenario
      • 9.2.2.5. Competitive Scenario
    • 9.2.3. Canada
      • 9.2.3.1. Canada Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.2.3.2. Key Country Dynamics
      • 9.2.3.3. Regulatory Framework
      • 9.2.3.4. Reimbursement Scenario
      • 9.2.3.5. Competitive Scenario
    • 9.2.4. Mexico
      • 9.2.4.1. Mexico Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.2.4.2. Key Country Dynamics
      • 9.2.4.3. Regulatory Framework
      • 9.2.4.4. Reimbursement Scenario
      • 9.2.4.5. Competitive Scenario
  • 9.3. Europe
    • 9.3.1. Europe Transplant Diagnostics Market, 2021 - 2033 (USD Million)
    • 9.3.2. UK
      • 9.3.2.1. UK Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.3.2.2. Key Country Dynamics
      • 9.3.2.3. Regulatory Framework
      • 9.3.2.4. Reimbursement Scenario
      • 9.3.2.5. Competitive Scenario
    • 9.3.3. Germany
      • 9.3.3.1. Germany Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.3.3.2. Key Country Dynamics
      • 9.3.3.3. Regulatory Framework
      • 9.3.3.4. Reimbursement Scenario
      • 9.3.3.5. Competitive Scenario
    • 9.3.4. Spain
      • 9.3.4.1. Spain Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.3.4.2. Key Country Dynamics
      • 9.3.4.3. Regulatory Framework
      • 9.3.4.4. Reimbursement Scenario
      • 9.3.4.5. Competitive Scenario
    • 9.3.5. France
      • 9.3.5.1. France Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.3.5.2. Key Country Dynamics
      • 9.3.5.3. Regulatory Framework
      • 9.3.5.4. Reimbursement Scenario
      • 9.3.5.5. Competitive Scenario
    • 9.3.6. Italy
      • 9.3.6.1. Italy Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.3.6.2. Key Country Dynamics
      • 9.3.6.3. Regulatory Framework
      • 9.3.6.4. Reimbursement Scenario
      • 9.3.6.5. Competitive Scenario
    • 9.3.7. Denmark
      • 9.3.7.1. Denmark Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.3.7.2. Key Country Dynamics
      • 9.3.7.3. Regulatory Framework
      • 9.3.7.4. Reimbursement Scenario
      • 9.3.7.5. Competitive Scenario
    • 9.3.8. Sweden
      • 9.3.8.1. Sweden Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.3.8.2. Key Country Dynamics
      • 9.3.8.3. Regulatory Framework
      • 9.3.8.4. Reimbursement Scenario
      • 9.3.8.5. Competitive Scenario
    • 9.3.9. Norway
      • 9.3.9.1. Norway Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.3.9.2. Key Country Dynamics
      • 9.3.9.3. Regulatory Framework
      • 9.3.9.4. Reimbursement Scenario
      • 9.3.9.5. Competitive Scenario
  • 9.4. Asia Pacific
    • 9.4.1. Asia-Pacific Transplant Diagnostics Market, 2021 - 2033 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Japan Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.4.2.2. Key Country Dynamics
      • 9.4.2.3. Regulatory Framework
      • 9.4.2.4. Reimbursement Scenario
      • 9.4.2.5. Competitive Scenario
    • 9.4.3. China
      • 9.4.3.1. China Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.4.3.2. Key Country Dynamics
      • 9.4.3.3. Regulatory Framework
      • 9.4.3.4. Reimbursement Scenario
      • 9.4.3.5. Competitive Scenario
    • 9.4.4. India
      • 9.4.4.1. India Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.4.4.2. Key Country Dynamics
      • 9.4.4.3. Regulatory Framework
      • 9.4.4.4. Reimbursement Scenario
      • 9.4.4.5. Competitive Scenario
    • 9.4.5. South Korea
      • 9.4.5.1. South Korea Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.4.5.2. Key Country Dynamics
      • 9.4.5.3. Regulatory Framework
      • 9.4.5.4. Reimbursement Scenario
      • 9.4.5.5. Competitive Scenario
    • 9.4.6. Thailand
      • 9.4.6.1. Thailand Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.4.6.2. Key Country Dynamics
      • 9.4.6.3. Regulatory Framework
      • 9.4.6.4. Reimbursement Scenario
      • 9.4.6.5. Competitive Scenario
    • 9.4.7. Australia
      • 9.4.7.1. Australia Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.4.7.2. Key Country Dynamics
      • 9.4.7.3. Regulatory Framework
      • 9.4.7.4. Reimbursement Scenario
      • 9.4.7.5. Competitive Scenario
  • 9.5. Latin America
    • 9.5.1. Latin America Transplant Diagnostics Market, 2021 - 2033 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Brazil Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.5.2.2. Key Country Dynamics
      • 9.5.2.3. Regulatory Framework
      • 9.5.2.4. Reimbursement Scenario
      • 9.5.2.5. Competitive Scenario
    • 9.5.3. Argentina
      • 9.5.3.1. Argentina Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.5.3.2. Key Country Dynamics
      • 9.5.3.3. Regulatory Framework
      • 9.5.3.4. Reimbursement Scenario
      • 9.5.3.5. Competitive Scenario
  • 9.6. MEA
    • 9.6.1. MEA Transplant Diagnostics Market, 2021 - 2033 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. South Africa Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.6.2.2. Key Country Dynamics
      • 9.6.2.3. Regulatory Framework
      • 9.6.2.4. Reimbursement Scenario
      • 9.6.2.5. Competitive Scenario
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Saudi Arabia Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.6.3.2. Key Country Dynamics
      • 9.6.3.3. Regulatory Framework
      • 9.6.3.4. Reimbursement Scenario
      • 9.6.3.5. Competitive Scenario
    • 9.6.4. UAE
      • 9.6.4.1. UAE Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.6.4.2. Key Country Dynamics
      • 9.6.4.3. Regulatory Framework
      • 9.6.4.4. Reimbursement Scenario
      • 9.6.4.5. Competitive Scenario
    • 9.6.5. Kuwait
      • 9.6.5.1. Kuwait Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.6.5.2. Key Country Dynamics
      • 9.6.5.3. Regulatory Framework
      • 9.6.5.4. Reimbursement Scenario
      • 9.6.5.5. Competitive Scenario

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Strategy Mapping
    • 10.2.1. New product launch
    • 10.2.2. Partnerships
    • 10.2.3. Acquisition
    • 10.2.4. Collaboration
    • 10.2.5. Funding
  • 10.3. Key Company Market Share Analysis, 2024
  • 10.4. Company Heat Map Analysis
  • 10.5. Company Profiles
    • 10.5.1. Thermo Fisher Scientific, Inc.
      • 10.5.1.1. Company Overview
      • 10.5.1.2. Financial Performance
      • 10.5.1.3. Product Benchmarking
      • 10.5.1.4. Strategic Initiatives
    • 10.5.2. Illumina, Inc.
      • 10.5.2.1. Company Overview
      • 10.5.2.2. Financial Performance
      • 10.5.2.3. Product Benchmarking
      • 10.5.2.4. Strategic Initiatives
    • 10.5.3. F. Hoffmann La-Roche Ltd
      • 10.5.3.1. Company Overview
      • 10.5.3.2. Financial Performance
      • 10.5.3.3. Product Benchmarking
      • 10.5.3.4. Strategic Initiatives
    • 10.5.4. Abbott
      • 10.5.4.1. Company Overview
      • 10.5.4.2. Financial Performance
      • 10.5.4.3. Product Benchmarking
      • 10.5.4.4. Strategic Initiatives
    • 10.5.5. QIAGEN
      • 10.5.5.1. Company Overview
      • 10.5.5.2. Financial Performance
      • 10.5.5.3. Product Benchmarking
      • 10.5.5.4. Strategic Initiatives
    • 10.5.6. Bruker
      • 10.5.6.1. Company Overview
      • 10.5.6.2. Financial Performance
      • 10.5.6.3. Product Benchmarking
      • 10.5.6.4. Strategic Initiatives
    • 10.5.7. BD (Becton, Dickinson and Company)
      • 10.5.7.1. Company Overview
      • 10.5.7.2. Financial Performance
      • 10.5.7.3. Product Benchmarking
      • 10.5.7.4. Strategic Initiatives
    • 10.5.8. Werfen (Immucor, Inc.)
      • 10.5.8.1. Company Overview
      • 10.5.8.2. Financial Performance
      • 10.5.8.3. Product Benchmarking
      • 10.5.8.4. Strategic Initiatives
    • 10.5.9. Bio-Rad Laboratories, Inc.
      • 10.5.9.1. Company Overview
      • 10.5.9.2. Financial Performance
      • 10.5.9.3. Product Benchmarking
      • 10.5.9.4. Strategic Initiatives
    • 10.5.10. Omixon Inc.
      • 10.5.10.1. Company Overview
      • 10.5.10.2. Financial Performance
      • 10.5.10.3. Product Benchmarking
      • 10.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 List Of Abbreviations
  • Table 3 Global Transplant Diagnostics Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 5 Global Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 6 Global Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 7 Global Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 8 Global Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 9 North America Transplant Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 10 North America Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 11 North America Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 12 North America Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 13 North America Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 14 North America Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 15 U.S. Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 16 U.S. Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 17 U.S. Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 18 U.S. Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 19 U.S. Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 20 Canada Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 21 Canada Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 22 Canada Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 23 Canada Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 24 Canada Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25 Mexico Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 26 Mexico Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 27 Mexico Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 28 Mexico Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 29 Mexico Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 Europe Transplant Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 31 Europe Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 32 Europe Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 33 Europe Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 34 Europe Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 35 Europe Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 36 UK Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 37 UK Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 38 UK Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 39 UK Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 40 UK Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 41 Germany Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 42 Germany Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 43 Germany Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 44 Germany Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 45 Germany Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 46 France Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 47 France Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 48 France Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 49 France Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 50 France Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 51 Italy Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 52 Italy Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 53 Italy Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 54 Italy Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 55 Italy Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 56 Spain Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 57 Spain Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 58 Spain Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 59 Spain Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 60 Spain Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 61 Sweden Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 62 Sweden Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 63 Sweden Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 64 Sweden Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 65 Sweden Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 66 Norway Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 67 Norway Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 68 Norway Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 69 Norway Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 70 Norway Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 71 Denmark Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 72 Denmark Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 73 Denmark Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 74 Denmark Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 75 Denmark Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 76 Asia Pacific Transplant Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 77 Asia Pacific Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 78 Asia Pacific Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 79 Asia-Pacific Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 80 Asia-Pacific Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 81 Asia Pacific Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 82 Japan Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 83 Japan Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 84 Japan Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 85 Japan Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 86 Japan Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87 China Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 88 China Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 89 China Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 90 China Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 91 China Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 92 India Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 93 India Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 94 India Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 95 India Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 96 India Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 97 Australia Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 98 Australia Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 99 Australia Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 100 Australia Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 101 Australia Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 102 Thailand Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 103 Thailand Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 104 Thailand Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 105 Thailand Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 106 Thailand Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 107 South Korea Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 108 South Korea Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 109 South Korea Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 110 South Korea Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 111 South Korea Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 112 Latin America Transplant Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 113 Latin America Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 114 Latin America Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 115 Latin America Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 116 Latin America Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 117 Latin America Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 118 Brazil Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 119 Brazil Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 120 Brazil Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 121 Brazil Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 122 Brazil Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 123 Argentina Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 124 Argentina Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 125 Argentina Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 126 Argentina Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 127 Argentina Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 128 MEA Transplant Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 129 MEA Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 130 MEA Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 131 MEA Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 132 MEA Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 133 MEA Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 134 South Africa Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 135 South Africa Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 136 South Africa Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 137 South Africa Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 138 South Africa Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 139 Saudi Arabia Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 140 Saudi Arabia Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 141 Saudi Arabia Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 142 Saudi Arabia Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 143 Saudi Arabia Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 144 UAE Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 145 UAE Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 146 UAE Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 147 UAE Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 148 UAE Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 149 Kuwait Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 150 Kuwait Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 151 Kuwait Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 152 Kuwait Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 153 Kuwait Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Transplant Diagnostics Market- Key market driver analysis
  • Fig. 7 Transplant Diagnostics Market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Transplant Diagnostics Market - Porter's analysis
  • Fig. 10 Transplant Diagnostics Market - PESTEL analysis
  • Fig. 11 Transplant Diagnostics Market Test outlook key takeaways
  • Fig. 12 Transplant Diagnostics Market: Test movement analysis
  • Fig. 13 Molecular Assays Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 14 PCR-based Molecular Assays Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 15 Real-time PCR Market estimates, 2021 - 2033 (USD Million)
  • Fig. 16 Sequence-based Primer-PCR Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 17 Sequence-specific Oligonucleotide-PCR Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 18 Other PCR-based Molecular Assays Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 19 Sequencing-based Molecular Assays Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 20 Sanger Sequencing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 21 Next Generation Sequencing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 22 Other Sequencing-based Molecular Assays Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 23 Non-molecular Assays Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 24 Serological Assays Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 25 Mixed Lymphocyte Culture Assays Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 26 Transplant Diagnostics Market Product Outlook Key Takeaways
  • Fig. 27 Transplant Diagnostics Market: Product Movement Analysis
  • Fig. 28 Reagents & Consumables Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 29 Instruments Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 30 Software and Services Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 31 Transplant Diagnostics Market Application Outlook Key Takeaways
  • Fig. 32 Transplant Diagnostics Market Application Movement Analysis
  • Fig. 33 Diagnostic Application Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 34 Infectious Disease Testing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 35 Histocompatibility Testing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 36 Blood Profiling Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 37 Research Application Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 38 Transplant Diagnostics Market Transplant Area Outlook Key Takeaways
  • Fig. 39 Transplant Diagnostics Market Transplant Area Movement Analysis
  • Fig. 40 Solid Area Transplantation Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 41 Kidney Transplantation Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 42 Liver Transplantation Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 43 Heart Transplantation Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 44 Lung Transplantation Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 45 Pancreas Transplantation Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 46 Other Organs Transplantation Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 47 Stem Cell Transplantation Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 48 Soft Tissue Transplantation Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 49 Bone Marrow Transplantation Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 50 Transplant Diagnostics Market End Use Outlook Key Takeaways
  • Fig. 51 Transplant Diagnostics Market End Use Movement Analysis
  • Fig. 52 Hospitals and Transplant Centers Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 53 Research and Academic Institutes Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 54 Independent Reference Laboratories Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 55 Regional marketplace: Key takeaways
  • Fig. 56 Global Transplant Diagnostics Market: Regional movement analysis
  • Fig. 57 North America Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 58 U.S. Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 59 Canada Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 60 Mexico Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 61 Europe Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 62 UK Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 63 Germany Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 64 France Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 65 Spain Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 66 Italy Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 67 Denmark Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 68 Sweden Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 69 Norway Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 70 Asia Pacific Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 71 Japan Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 72 China Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 73 India Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 74 South Korea Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 75 Australia Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 76 Thailand Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 77 Latin America Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 78 Brazil Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 79 Argentina Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 80 MEA Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 81 South Africa Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 82 Saudi Arabia Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 83 UAE Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 84 Kuwait Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 85 Strategy framework